Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J. Peluso, Timothy J. Henrich, Keirstinne Turcios et al.|Cell Reports|2021Cited by 266
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological ManifestationsBing Sun, Lynn Pulliam, Norina Tang et al.|Cells|2021Cited by 187
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J. Peluso, Bryan Greenhouse, Saki Takahashi et al.|Science Advances|2021Cited by 150
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patientsJoanna Hellmuth, Michael J. Peluso, T. Allen Barnett et al.|Journal of NeuroVirology|2021Cited by 144
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detectionSusanna K. Elledge, James A. Wells, Xin Zhou et al.|Nature Biotechnology|2021Cited by 142